183 related articles for article (PubMed ID: 24282590)
1. Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers.
Zhang H; Su Y; Xu F; Kong J; Yu H; Qian B
PLoS One; 2013; 8(11):e81408. PubMed ID: 24282590
[TBL] [Abstract][Full Text] [Related]
2. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.
Xu F; Zhang H; Su Y; Kong J; Yu H; Qian B
Clin Transl Oncol; 2014 Nov; 16(11):980-5. PubMed ID: 24805982
[TBL] [Abstract][Full Text] [Related]
5. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
Hanafi AR; Jayusman AM; Alfasunu S; Sadewa AH; Pramono D; Heriyanto DS; Haryana SM
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):321-332. PubMed ID: 32283582
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.
Zhao Q; Cao J; Wu YC; Liu X; Han J; Huang XC; Jiang LH; Hou XX; Mao WM; Ling ZQ
Am J Cancer Res; 2015; 5(5):1692-705. PubMed ID: 26175938
[TBL] [Abstract][Full Text] [Related]
7. Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation.
Erdogan B; Kodaz H; Karabulut S; Cinkaya A; Tozkir H; Tanriverdi O; Cabuk D; Hacioglu MB; Turkmen E; Hacibekiroglu I; Uzunoglu S; Cicin I
Bosn J Basic Med Sci; 2016 Nov; 16(4):280-285. PubMed ID: 27371767
[TBL] [Abstract][Full Text] [Related]
8. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
Seike M; Goto A; Okano T; Bowman ED; Schetter AJ; Horikawa I; Mathe EA; Jen J; Yang P; Sugimura H; Gemma A; Kudoh S; Croce CM; Harris CC
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12085-90. PubMed ID: 19597153
[TBL] [Abstract][Full Text] [Related]
9. Unique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma.
Ito S; Kamoto Y; Sakai A; Sasai K; Hayashi T; Toyooka S; Katayama H
Oncotarget; 2017 Dec; 8(70):114685-114697. PubMed ID: 29383112
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients.
Hojbjerg JA; Ebert EBF; Clement MS; Winther-Larsen A; Meldgaard P; Sorensen B
Lung Cancer; 2019 Sep; 135():92-96. PubMed ID: 31447008
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 25, microRNA 145, and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations.
Shi SB; Wang M; Tian J; Li R; Chang CX; Qi JL
Transl Res; 2016 Apr; 170():1-7. PubMed ID: 26687391
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
13. microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation.
Shen Y; Tang D; Yao R; Wang M; Wang Y; Yao Y; Li X; Zhang H
Med Oncol; 2013 Dec; 30(4):750. PubMed ID: 24198203
[TBL] [Abstract][Full Text] [Related]
14. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
15. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
16. Clinic significance of microRNA-99a expression in human lung adenocarcinoma.
Gu W; Fang S; Gao L; Tan Y; Yang Z
J Surg Oncol; 2013 Sep; 108(4):248-55. PubMed ID: 23893385
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
18. Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.
Pan YQ; Shi WW; Xu DP; Xu HH; Zhou MY; Yan WH
Chin Med Sci J; 2014 Sep; 29(3):156-61. PubMed ID: 25264883
[TBL] [Abstract][Full Text] [Related]
19. Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Jain A; Lim C; Gan EM; Ng DZ; Ng QS; Ang MK; Takano A; Chan KS; Tan WM; Kanesvaran R; Toh CK; Loo CM; Hsu AA; Devanand A; Lim CH; Koong HN; Koh T; Fong KW; Yap SP; Kim SW; Chowbay B; Oon L; Lim KH; Lim WT; Tan EH; Tan DS
PLoS One; 2015; 10(5):e0123587. PubMed ID: 25955322
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
Cheng MW; Shen ZT; Hu GY; Luo LG
Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
